Pediatric Differentiated Thyroid Carcinoma: Insights from the Child and Adolescent Thyroid Consortium on Invasive Disease Predictors and Treatment Outcomes
Pediatric differentiated thyroid carcinoma (DTC) predominantly affects females and is mostly papillary thyroid carcinoma (PTC).
Males and children younger than 10 years have a higher likelihood of presenting with invasive disease including advanced tumor stage and metastases.
Tumors harboring oncogenic fusions are associated with more advanced nodal and distant metastatic involvement compared with BRAFV600E mutations.
Despite therapy deintensification implemented since 2015, disease outcomes have not deteriorated, supporting less aggressive treatment strategies in selected cases.